Icahn School of Medicine at Mount Sinai
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Icahn School of Medicine at Mount Sinai sits in the top decile of US sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count).
Icahn School of Medicine at Mount Sinai: 708 sponsored US clinical trials, 163 recruiting.
Icahn School of Medicine at Mount Sinai sponsors 708 registered US clinical trials on ClinicalTrials.gov, 163 of them currently recruiting, and 423 completed. 88 of these trials are in Phase 3-4 (later-stage) and 138 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 7 trials.
Top-decile sponsor footprint
Icahn School of Medicine at Mount Sinai ranks in the top decile of sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
423 of 499 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
708 total, page 10 of 15
Secukinumab for Treatment of Atopic Dermatitis
NCT02594098
Self-directed Video Versus Instructor-based Neonatal Resuscitation Training
NCT01847911
Family-based Approach to Promotion of Health - FAMILIA (Project 2)
NCT02481401
Autonomic Neuropathy, GI Motility, and Inflammation in HIV
NCT02850276
Family-based Approach to Promotion of Health - FAMILIA (Project 1)
NCT02343341
A Study of Secukinumab for the Treatment of Alopecia Areata
NCT02599129
Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
NCT02334683
Utility of Ultrasound Assessment of the Inferior Vena Cava in Patients With Sepsis and Dehydration
NCT02568189
Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease
NCT02560168
Optimizing Postoperative Cognition the Elderly
NCT02650687
Targeting Platelets in Chronic HIV Infection
NCT02578706
Large Scale Cerebral Oximetry During Sinus Endoscopy
NCT02692794
Non Invasive Neuromonitoring After Cardiac Arrest
NCT02575196
Treating Cancer-Related Fatigue Through Systematic Light Exposure (Light for Fatigue Study)
NCT03119363
Mitochondrial Dysfunction and Disease Progression
NCT02549703
The Effects of Ondansetron on Brain Function
NCT02460341
Trajectory of Recovery in the Elderly
NCT02275026
Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
NCT02270242
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
NCT02427204
The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness
NCT02423512
Biomarkers of Liver Fibrosis
NCT02438917
Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)
NCT02397889
Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment
NCT02473419
The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair
NCT02502838
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry
NCT02362659
STRIPES Study: Study To Reduce Infection Post cEsarean Section
NCT02402907
Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes
NCT02325466
Asthma Mobile Health Application 2.0
NCT03248869
NICU-HEALTH (Hospital Exposures and Long-Term Health)
NCT01963065
Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department
NCT02399969
Self-injection and Self-management
NCT02417493
Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
NCT02397876
Malnutrition Associated With Complications After Ileostomy Reversal
NCT03909542
Neuroprotection in Patients Undergoing Aortic Valve Replacement
NCT02389894
Treatment of Actinic Keratoses (AK) on the Face
NCT02411851
Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life
NCT02322307
Minimally Invasive Surgery (MIS) for Spine Metastases
NCT02367378
Does the Addition of Epinephrine Prolong the Duration of Spinal Anesthesia for Repeat Cesarean Section?
NCT02369510
Adult Liver Transplant Enhanced Care
NCT02320422
Supporting Asthma Management Behaviors in Aging Adults
NCT02316223
Precision IFX: Using a Dashboard to Individualize Infliximab Dosage
NCT02624037
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood
NCT02718573
Food Preparation Effects on Gut Bacteria in Patients on Peritoneal Dialysis
NCT02467530
Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer
NCT02363647
Neurodevelopmental Outcomes of Preterm and Term Children
NCT02309697
Single-centre, Registry Trial, the Patients Presented With Stable Coronary Artery Disease
NCT02364778
Psychosocial Risks in Liver Transplant Recipients
NCT02826460
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma
NCT02513199
Foley Labor Induction Trial at Term and in PROM
NCT02098421
Genetic Testing to Understand and Address Renal Disease Disparities
NCT02234063
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 81 |
| Phase 3 | 21 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Icahn School of Medicine at Mount Sinai pipeline
163 recruiting of 708 indexed (23% open); 423 completed (60%).
Phase mix: 88 late (III/IV) vs 138 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Icahn School of Medicine at Mount Sinai: open-pipeline peers nationwide
Peers matched on 708 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Icahn School of Medicine at Mount Sinai sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 708 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
- University of Miami · 721 trials · 20% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Icahn School of Medicine at Mount Sinai page
708 registered trials is a research-attention snapshot, not an endorsement of Icahn School of Medicine at Mount Sinai or any single study.
- 163 of Icahn School of Medicine at Mount Sinai's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Icahn School of Medicine at Mount Sinai studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Icahn School of Medicine at Mount Sinai pipeline card: 708 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.